Xeljanz Manufacturers Fail to Warn Consumers
In July of 2019, the Food and Drug Administration (FDA) approved a new boxed warning for Xeljanz and Xeljanz XR regarding the risks of blood clots and potential death for users of the drug. Manufacturers of Xeljanz were previously made…
Read More